Stockert GmbH

The company researches, develops, manufactures and sells medical electronic devices, instruments, appliances and aids as well as measurement, control and regulation technology and information technology. Stockert supplies B2B partners and large medical technology companies worldwide and distributes products via distributors in well over 100 countries; the foreign/EU share of revenue was about 91% in 2023. Main target markets are cardiology (in particular radiofrequency ablation of the heart) and neurology (RF pain therapy and nerve stimulation), and the company states it is world market leader in RF ablation in cardiology and in stimulation for peripheral nerve blocks. In fiscal year 2023 an average of 75 full-time equivalents were employed; 21 FTE worked in R&D and significant investments were made in research and development.